The Billion-Euro European Biotech Companies in 2022
Here’s a list of the public European biotech companies that are worth more than a…
December 20, 2021 - 12 minutes
Galapagos
Delayed IPOs and Market Drops Batter Biotech Stocks
Stock markets worldwide have experienced painful instability in the last few months. As a result,…
May 25, 2021 - 6 minutes
Galapagos and Gilead Soldier On After Inflammatory Disease Flops
Clinical and regulatory setbacks have left the star biotech duo Gilead and Galapagos smarting and…
March 4, 2021 - 4 minutes
A Year to Remember: The Biggest European Biotech News in 2020
The Covid-19 pandemic caused huge disruption for European biotech in 2020, but the industry pulled…
December 28, 2020 - 12 minutes
Galapagos’ Arthritis Drug Approved in EU and Japan Amid US Rejection
The recent EU and Japan approvals of the rheumatoid arthritis drug filgotinib contrast with the…
October 5, 2020 - 5 minutes
MorphoSys and Galapagos’ Eczema Drug Abandoned at Phase II
Development of MorphoSys, Galapagos, and Novartis’ first-in-class antibody drug has been discontinued during a phase…
October 29, 2019 - 2 minutes
Gilead Pays Billions for Access to Galapagos’ Pipeline
Gilead has launched a 10-year collaboration with the Belgo-Dutch biotech Galapagos, paying at least €4.5B…
July 15, 2019 - 2 minutes
Why Sticking to Your Beliefs is Important for Biotech Success
Galapagos is an undeniable success story. Set up in 1999, it is now one of…
June 8, 2019 - 11 minutes
The 8 Best Biotech Companies in Europe’s History
We’ve put together a list of the best biotech companies in Europe to celebrate their…
April 2, 2019 - 8 minutes
Galapagos Nears First Drug Approval with Phase III Success in Rheumatoid Arthritis
Galapagos has released positive data from two phase III trials testing its flagship drug candidate,…
March 29, 2019 - 3 minutes
Bridging the Academia-Industry Divide: Lessons from a Serial Biotech Entrepreneur
What does it take to be a successful biotech entrepreneur? I put this and other…
October 23, 2018 - 8 minutes
Morphosys and Galapagos Announce Positive Phase I Results for Atopic Dermatitis Treatment
Phase I results show promise for a new treatment for atopic dermatitis that may become…
February 20, 2018 - 3 minutes
